InterventionsHuman trial

Safety, Pharmacokinetics, and Weight Loss Effects of the Oral GLP-1/GIP Dual Agonist BGM0504 in Healthy and Overweight or Obese Adults: A Phase 1 Multiple-Ascending Dose Study

ADA Scientific Sessions 2026 Abstract

The paper

Jiandong Yuan, Daosheng Xie, Yangqing Huang,
Show 2 more authorsHaifeng Ding, Steve Chen,
Xiaohui Jiang

Suzhou

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2845-LB

doi.org/10.2337/db26-2845-lb

Related